Is a  total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?

CONCLUSION: These retrospective data suggest that a dose reduction may be possible for intermediate-risk volumes, especially for the primary site.PMID:38153435 | DOI:10.1007/s00066-023-02186-3

Source: Cancer Control - December 28, 2023 Category: Cancer & Oncology Authors: Meltem Da ğdelen Tuba Kurt Çatal Song ül Çavdar Karaçam Emine Sedef Akoval ı Sevda Kanat Halil Cumhur Y ıldırım Ömer Erol Uzel Source Type: research